Sarepta Therapeutics Inc (NASDAQ: SRPT) stock closed at $160.72 on 6/21/24 after a major increase of 30.1%. Moreover, trading volume in this advance was exceptionally high at 808% of normal. The stock has risen 34.0% during the last week and has been exceptionally strong relative to the market over the last nine months.
Current PriceTarget Research Rating
SRPT is expected to be a major Value Builder reflecting capital returns that are forecasted to be above the cost of capital.
Sarepta Therapeutics has a current Value Trend Rating of A (Highest Rating). The Value Trend Rating reflects consistent signals from PTR’s two proprietary measures of a stock’s attractiveness. Sarepta Therapeutics has a good Appreciation Score of 71 and a very high Power Rating of 89, resulting in the Highest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of A. This review will be completed in the next several days.
Be the first to comment